The Australian Technical Advisory Group on Immunisation (ATAGI) has recommended that more people from 16 to 64 years old be given a fourth ‘winter’ dose of COVID-19 vaccine.
- Cancer 
- Chronic inflammatory conditions: Systemic lupus erythematosus, rheumatoid arthritis, Crohn’s disease, ulcerative colitis, … 
- Chronic lung disease: including severe asthma (requiring frequent hospital visits or the use of multiple medications). 
- Chronic liver disease 
- Severe chronic kidney disease (stage 4 or 5) 
- Chronic neurological disease: stroke, dementia, epilepsy, … 
- Diabetes mellitus requiring medication 
- Chronic cardiac disease 
- People with disability with significant or complex health needs 
- Severe obesity with BMI ≥ 40 kg/m2 
- Severe underweight with BMI < 16.5 kg/m2 
 
                
              